Bristol-Myers Squibb Company (BMY)

May 28, 2025, 6:50 PM EDT - 3 days ago

Bristol-Myers Squibb Company (BMY) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

May 28, 2025, 10:07 AM EDT - 3 days ago

Bristol-Myers Squibb's Painful Pullback Has Triggered Richer Dividend Story - Upgrade To Buy

May 28, 2025, 6:59 AM EDT - 3 days ago

Bristol Myers Squibb to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025, 6:55 AM EDT - 3 days ago

Bristol Myers Squibb Receives European Commission Approval for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications

May 27, 2025, 4:42 PM EDT - 4 days ago

Bristol-Myers Squibb: This Undervalued Dog Needs An Option Collar

May 27, 2025, 12:16 PM EDT - 4 days ago

Bristol-Myers: Among The Cheapest Pharma Names, Now Yielding Above 5%

May 27, 2025, 9:14 AM EDT - 4 days ago

Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence

May 26, 2025, 11:45 AM EDT - 5 days ago

When It Rains Gold, Put Out The Bucket: 2 Wonderful Income Bargains

REXR

May 23, 2025, 8:15 AM EDT - 8 days ago

Avoid These Dividend Disasters Before It's Too Late

AMGN COP CVS CVX DLR GNL HD

May 22, 2025, 5:05 PM EDT - 9 days ago

Bristol Myers Squibb to Present Data at ASCO® 2025 Highlighting Differentiated Research Platform of Oncology Treatments and Innovative Research Pipeline

May 21, 2025, 4:20 PM EDT - 10 days ago

Buy 9 Barron's Better Bets (Than T-Bills) From 16 'Safer' May Dividend Dogs

BBY CAG ETR FRT KIM LYB MO

May 21, 2025, 6:59 AM EDT - 10 days ago

Bristol Myers Squibb to Participate in the Bernstein 41st Annual Strategic Decisions Conference

May 19, 2025, 1:00 PM EDT - 12 days ago

Buy These 2 Beaten Down Stocks Now Before They Rally

AAT ARE PFE

May 18, 2025, 8:35 AM EDT - 13 days ago

5 Dirt-Cheap Dividends Paying Up To 7.6%

AES AESI DINO PII

May 16, 2025, 6:59 AM EDT - 15 days ago

Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%

May 15, 2025, 6:27 PM EDT - 16 days ago

Final Trade: RIO, FCX, X, BMY

FCX RIO X

May 14, 2025, 8:00 PM EDT - 17 days ago

Jim Cramer talks good companies getting pummeled by rising interest rates

ABBV CL GM JNJ PEP PG

May 12, 2025, 12:30 PM EDT - 19 days ago

Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet

ABBV AMGN BIIB GILD JNJ LLY MRK

May 9, 2025, 8:35 PM EDT - 22 days ago

Hawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning label

SNY

May 8, 2025, 7:23 PM EDT - 23 days ago

Pressure is still on the pharma sector, says Mizuho's Jared Holz

ABBV AMGN GILD JNJ LLY MRK NVO

May 8, 2025, 9:00 AM EDT - 23 days ago

Dividend Harvesting Portfolio Week 218: $21,800 Allocated, $2,195.04 In Projected Dividends

BP BTI MO PFE SLG

May 6, 2025, 7:50 AM EDT - 25 days ago

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

PINC VTRS

May 6, 2025, 6:59 AM EDT - 25 days ago

Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer

May 5, 2025, 5:23 PM EDT - 26 days ago

Bristol Myers to invest $40 billion in the US over 5 years, CEO says

Apr 28, 2025, 7:16 AM EDT - 4 weeks ago

Top 3 Health Care Stocks That May Rocket Higher In April

UNH XFOR

Apr 28, 2025, 7:15 AM EDT - 4 weeks ago

Retirement Strategy: 2 Blue Chip Dividends Now Way Too Cheap

VZ

Apr 25, 2025, 6:06 PM EDT - 5 weeks ago

We're in a pharma stock pickers market, says Kessef's Len Yaffe

ABBV GILD JNJ LLY MRK PFE REGN

Apr 25, 2025, 10:27 AM EDT - 5 weeks ago

5 Positives From Bristol-Myers Squibb's Q1 2025 Results

Apr 25, 2025, 9:53 AM EDT - 5 weeks ago

Exclusive: US pharma tariffs would raise US drug costs by $51 bln annually, report finds

AMGN LLY PFE

Apr 25, 2025, 9:00 AM EDT - 5 weeks ago

Bristol-Myers: Undervalued, Delivering Increased 2025 Guidance

Apr 24, 2025, 1:11 PM EDT - 5 weeks ago

Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results

Apr 24, 2025, 12:01 PM EDT - 5 weeks ago

Bristol-Myers Squibb Company (BMY) Q1 2025 Earnings Call Transcript

Apr 24, 2025, 11:56 AM EDT - 5 weeks ago

Bristol-Myers Squibb Is A Good Pick

Apr 24, 2025, 11:22 AM EDT - 5 weeks ago

Bristol-Myers Q1 Earnings Review: A Decidedly Mixed Bag - Rating Downgrade

Apr 24, 2025, 7:13 AM EDT - 5 weeks ago

Bristol Myers Squibb Posts Better-than-Expected Earnings, Raises Full-Year Guidance

Apr 24, 2025, 7:03 AM EDT - 5 weeks ago

Bristol Myers posts better-than-expected quarterly revenue on strong cancer drug sales

Apr 24, 2025, 7:01 AM EDT - 5 weeks ago

Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs

Apr 24, 2025, 6:59 AM EDT - 5 weeks ago

Bristol Myers Squibb Reports First Quarter Financial Results for 2025

Apr 23, 2025, 9:55 AM EDT - 5 weeks ago

Bristol Myers' Cobenfy Falls Short On Primary Endpoint In Phase 3 Schizophrenia Trial, Stock Slides

Apr 23, 2025, 8:12 AM EDT - 5 weeks ago

Bristol Myers Stock Falls After Drug Trial Setback. Why 1 Analyst Isn't Worried.

Apr 22, 2025, 4:22 PM EDT - 5 weeks ago

Bristol Myers' Cobenfy fails to meet main goal as add-on treatment for schizophrenia

Apr 22, 2025, 4:15 PM EDT - 5 weeks ago

Bristol Myers Squibb Announces Topline Results from Phase 3 ARISE Trial Evaluating Cobenfy (xanomeline and trospium chloride) as an Adjunctive Treatment to Atypical Antipsychotics in Adults with Schizophrenia

Apr 22, 2025, 6:21 AM EDT - 5 weeks ago

Bristol-Myers Squibb: Extraordinary Dividend And FCF Yields Ready For Recession

Apr 21, 2025, 9:00 AM EDT - 5 weeks ago

LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed

ABBV AMGN AZN GSK JNJ LLY MRK

Apr 17, 2025, 8:21 PM EDT - 6 weeks ago

U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications

Apr 16, 2025, 5:16 PM EDT - 6 weeks ago

2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVT

TSVT

Apr 15, 2025, 3:53 PM EDT - 6 weeks ago

Why Is US Pharma Giant Bristol Myers Squibb Stock Trading Lower On Tuesday?

Apr 14, 2025, 4:24 PM EDT - 6 weeks ago

Bristol Myers' heart disease drug fails to meet main goals in late-stage study

Apr 14, 2025, 4:15 PM EDT - 6 weeks ago

Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial